You are here: Industry Insights > Allplex

News List

Seegene's Germany subsidiary supports the back-to-school initiative with its COVID-19 tests prnasia
May 11, 2021
Seegene Inc. (KQ 096530), a leading molecular diagnostics firm said its German subsidiary, Seegene Germany GmbH is taking part in the government's Back-to-School program called the "Lolli-Test," a starting point in returning our daily lives back to ...
Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year prnasia
April 22, 2021
Seegene Inc., a leading biotechnology firm said it began supplying its COVID-19 diagnostic tests worth 16,209,150 GBP to Scotland under a public procurement agreement, the largest diagnostic volume seen in that region since the pandemic.
Seegene's Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants prnasia
March 03, 2021
Seegene said Wednesday it finished the development of the world's first-ever variant diagnostic test that can simultaneously detect COVID-19 and screen multiple virus variants, with a single multiplex real-time PCR testing.
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants prnasia
February 01, 2021
South Korea's biotechnology firm Seegene (KQ096530) said Monday it developed the world's first COVID-19 diagnostic variant test, capable of screening COVID-19 and identifying multiple mutant variations in a single reaction.
Seegene's COVID-19 test with saliva sample collection feature now available in Europe prnewswire
January 07, 2021
South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Tuesday that it has CE-IVD marked the saliva-based testing application for Allplex™ SARS-CoV-2 Assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay ...